Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Dr. Bienvenue is currently a Senior Director at Aptevo Therapeutics, where he manages the Protein Sciences group and leads the Early Product Development (EPD) team. His team focuses on the stability and manufacturability of ADAPTIR bispecific proteins to identify lead clinical candidates.